Welcome to the USAID-funded Health Policy Plus (HP+) project website.
Links to documents and external sites open in a new window.
Links to documents and external sites open in a new window.
In Ouagadougou on September 25, 2021, 956 people received COVID-19 vaccines in one day, representing twice the daily average of people vaccinated in all the 88 vaccination sites in the Central Region since the start of Burkina Faso’s COVID-19 vaccine roll out. The mass vaccination event for adults was hosted by the U.S. Embassy in collaboration with the Ministry of Health and organized by HP+, which also managed transportation logistics for vaccine delivery, promoted participation through traditional and social media, and coordinated and supervised the team administering the vaccines. The vaccines administered were part of a shipment of 302,600 doses of the Johnson & Johnson vaccine provided by the U.S. Government, which supports immunization in Burkina Faso through the COVAX initiative and a bilateral partnership. This one-day event was a major boost to the country’s vaccination effort, which was launched on June 2, 2021. Prior to the event, only 2.4 percent of the country's targeted population was immunized. General Secretary of the Ministry of Health, Dr. Wilfried Ouedraogo, praised the initiative and support of the U.S. Government to mitigating the impact of COVID-19 in Burkina Faso.
In Ouagadougou on September 25, 2021, 956 people received COVID-19 vaccines in one day, representing twice the daily average of people vaccinated in all the 88 vaccination sites in the Central Region since the start of Burkina Faso’s COVID-19 vaccine roll out. The mass vaccination event for adults was hosted by the U.S. Embassy in collaboration with the Ministry of Health and organized by HP+, which also managed transportation logistics for vaccine delivery, promoted participation through traditional and social media, and coordinated and supervised the team administering the vaccines. The vaccines administered were part of a shipment of 302,600 doses of the Johnson & Johnson vaccine provided by the U.S. Government, which supports immunization in Burkina Faso through the COVAX initiative and a bilateral partnership. This one-day event was a major boost to the country’s vaccination effort, which was launched on June 2, 2021. Prior to the event, only 2.4 percent of the country's targeted population was immunized. General Secretary of the Ministry of Health, Dr. Wilfried Ouedraogo, praised the initiative and support of the U.S. Government to mitigating the impact of COVID-19 in Burkina Faso.
In Ouagadougou on September 25, 2021, 956 people received COVID-19 vaccines in one day, representing twice the daily average of people vaccinated in all the 88 vaccination sites in the Central Region since the start of Burkina Faso’s COVID-19 vaccine roll out. The mass vaccination event for adults was hosted by the U.S. Embassy in collaboration with the Ministry of Health and organized by HP+, which also managed transportation logistics for vaccine delivery, promoted participation through traditional and social media, and coordinated and supervised the team administering the vaccines. The vaccines administered were part of a shipment of 302,600 doses of the Johnson & Johnson vaccine provided by the U.S. Government, which supports immunization in Burkina Faso through the COVAX initiative and a bilateral partnership. This one-day event was a major boost to the country’s vaccination effort, which was launched on June 2, 2021. Prior to the event, only 2.4 percent of the country's targeted population was immunized. General Secretary of the Ministry of Health, Dr. Wilfried Ouedraogo, praised the initiative and support of the U.S. Government to mitigating the impact of COVID-19 in Burkina Faso.
